These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2873986)
1. Disposition of (5H-dibenzo [a,d]cyclohepten-5-ylidene)acetic acid in laboratory animals. Schillings RT; Sisenwine SF Drug Metab Dispos; 1986; 14(4):405-12. PubMed ID: 2873986 [TBL] [Abstract][Full Text] [Related]
2. Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys. Hucker HB; Hutt JE; White SD; Arison BH; Zacchei AG Drug Metab Dispos; 1983; 11(1):54-8. PubMed ID: 6132797 [TBL] [Abstract][Full Text] [Related]
3. Disposition of flavodilol in laboratory animals. Coan M; Simmons R Drug Metab Dispos; 1989; 17(4):420-5. PubMed ID: 2571483 [TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
6. The metabolic disposition of etodolac in rats, dogs, and man. Cayen MN; Kraml M; Ferdinandi ES; Greselin E; Dvornik D Drug Metab Rev; 1981; 12(2):339-62. PubMed ID: 6461537 [TBL] [Abstract][Full Text] [Related]
7. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs. Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of a novel butylated hydroxytoluene-thiazolidinone CNS antiischemic agent LY256548 in rats, mice, dogs, and monkeys. Ruterbories KJ; Lindstrom TD Drug Metab Dispos; 1990; 18(5):674-9. PubMed ID: 1981719 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic disposition of guanabenz in the rhesus monkey. Meacham RH; Chiang ST; Kick CJ; Sisenwine SF; Jusko WJ; Ruelius HW Drug Metab Dispos; 1981; 9(6):509-14. PubMed ID: 6120807 [TBL] [Abstract][Full Text] [Related]
10. Disposition of salmeterol xinafoate in laboratory animals and humans. Manchee GR; Barrow A; Kulkarni S; Palmer E; Oxford J; Colthup PV; Maconochie JG; Tarbit MH Drug Metab Dispos; 1993; 21(6):1022-8. PubMed ID: 7905380 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine. Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of indecainide in mice, rats, dogs, and monkeys. Lindstrom TD; Whitaker GW Drug Metab Dispos; 1984; 12(6):683-90. PubMed ID: 6150816 [TBL] [Abstract][Full Text] [Related]
13. Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys. Cayen MN; Hicks DR; Ferdinandi ES; Kraml M; Greselin E; Dvornik D Drug Metab Dispos; 1985; 13(4):412-9. PubMed ID: 2863103 [TBL] [Abstract][Full Text] [Related]
14. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys. Manzione BM; Bernstein JR; Franklin RB Drug Metab Dispos; 1991; 19(1):54-60. PubMed ID: 1673422 [TBL] [Abstract][Full Text] [Related]
15. Disposition of remoxipride in different species. Species differences in metabolism. Widman M; Nilsson LB; Bryske B; Lundström J Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555 [TBL] [Abstract][Full Text] [Related]
16. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
17. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
18. Disposition of a new nonsteroidal anti-inflammatory agent, S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid, in rats, dogs and monkeys. Konishi T; Okada S; Nishikawa H; Esumi Y; Kitamura S; Tatsumi K Arzneimittelforschung; 1998 Mar; 48(3):266-74. PubMed ID: 9553685 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs. Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219 [TBL] [Abstract][Full Text] [Related]
20. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys. Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]